Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2074.6000
35.40
(
1.74
%)
NSE
Jan 06, 2026
15:53 PM
62.65% Gain from 52W Low
Volume:
223.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
24 Aug 2023
2074.60
1.74%
GLENMARK PHARMACEUTICALS
Hold:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 815
Target
Geojit BNP Paribas
Glenmark Pharma has gained
26.80%
in the last 1 Year
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five stocks to buy from analysts this week - January 6, 2026
The Baseline |
06 Jan 2026, 04:16PM
Market closes lower, dragged down by foreign investor outflow and oil & gas stocks
Trendlyne Marketwatch |
06 Jan 2026, 04:15PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020